August 1, 2022 Miscellaneous

Protocol: Alliance – A151804

SCHEMA Alliance A151804

Please Note: Below is partial eligibility, for full eligibility requirement’s, please contact GHCI Research Department at (810) 762-8181, (810) 762-8079 and/or (810) 762-8038. Thank you!

Pre-Eligibility:

  1. Planning to receive a regimen containing one or more immuno-oncology (IO) therapeutics. Note: Contact GHCI Research Dept., to discuss allowable therapeutic agents.
  2. Has not previously been treated with CTLA-4, PD-1 or PD-L1 inhibitors.
  3. Willing and able to provide baseline blood and stool samples.

Eligibility:

  1. Receiving one or more of the allowed therapeutic agents.
  2. Experienced one or more serious AEs.

Genesys Hurley Cancer Institute

302 Kensington Avenue (Print a Map)
Flint, MI 48503

810-762-8226 | 888-762-8675

Ascension Genesys Hospital
Hurley Medical Center
Michigan Cancer Consortium

Newsletter

Ⓒ 2020 Genesys Hurley Cancer Institute | All Rights Reserved.